-
Zdravljenje lizosomskih bolezni - sedanjost in prihodnost = Treatment of lysosomal storage disease - present and futureŽerjav-Tanšek, Mojca ...There are more than 40 different forms of inherited lysosomal storage diseases(LSD) known to occur in humans and the aggregate incidence has been estimated to approach 1 in 7.000 to 8.000 live ... births. Deficient activity of any one of numerous lysosomal enzymes results in a specific lysosomal storage disorder, due to the progressme storage ot tne substrate in affected organs and tissues. Sphingolipidoses, mucopolysaccharidoses and oligosaccharidoses are the main groups of lysosomal diseases and despite a great variability theyshare some clinical manifestations. Most LSDs are associated with high morbidity and mortality and represent a significant burden on patients, their families, and health care providers. Except for symptomatic therapies, many LSDs remain untreatable. Animal models of LSDs play a critical role in evaluating the efficacy and safety of therapy for many of these conditions. Therapies for some LSDs do exist, or are under evaluation, including allogenicbone marrow transplantation, enzyme replacement therapy (ERT), and enzyme enhancement therapy. These treatment options are associated with significant concerns, including high morbidity and mortality with limited positive outcomes in bone marrow or hematopoietic stem cell transplantation, incomplete response to therapy and life-long therapy in ERT and high costs of therapies. ERT in Gaucher and Fabry disease is successful if the therapy is introduced early and with sufficient dosage. ERT in LSD is reviewed regarding history, biochemical features, efficiency in clinical studies and side effects. The other therapies for some LSDs are reviewed shortly.Source: Slovenska pediatrija : revija Združenja pediatrov Slovenije in Združenja specialistov šolske in visokošolske medicine Slovenije. - ISSN 1318-4423 (Letn. 13, št. 1, 2006, str. 6-19)Type of material - article, component partPublish date - 2006Language - slovenianCOBISS.SI-ID - 21325785
Author
Žerjav-Tanšek, Mojca |
Kitanovski, Lidija |
Benedik-Dolničar, Majda |
Battelino, Tadej
Topics
Lysosomal Storage Diseases |
Diagnosis |
Therapy |
Sphingolipidoses |
Mucopolysaccharidoses |
Oligosaccharides |
Bone Marrow Transplantation |
Hematopoietic Stem Cell Transplantation |
Gaucher'S Disease |
Fabry'S Disease |
Kostni mozeg, presaditev |
Lizosomsko shranjevanje, bolezni |
Mukopolisaharidoze |
Oligosaharidi |
Sfingolipidoze |
Hematopoetska matična celica, presaditev
![loading ... loading ...](themes/default/img/ajax-loading.gif)
![loading ... loading ...](themes/default/img/ajax-loading.gif)
![loading ... loading ...](themes/default/img/ajax-loading.gif)
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|---|
Žerjav-Tanšek, Mojca | 15440 |
Kitanovski, Lidija | 19257 |
Benedik-Dolničar, Majda | 03564 |
Battelino, Tadej | 13023 |
Select pickup location:
Material pickup by post
Notification
Subject headings in COBISS General List of Subject Headings
Select pickup location
Pickup location | Material status | Reservation |
---|
Please wait a moment.